Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04802720
Other study ID # 20-407
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 26, 2021
Est. completion date January 8, 2025

Study information

Verified date May 2024
Source Memorial Sloan Kettering Cancer Center
Contact Allison Applebaum, PhD
Phone 646-888-0034
Email applebaa@mskcc.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare two types of therapy for caregivers of cancer patients: Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy (CBT-C). The researchers want to see if ERT-C is better than, the same as, or worse than traditional CBT-C at improving caregiver distress. The researchers will look at how the two types of therapy affect caregivers' anxiety, depression, and quality of life. The researchers will also see how ERT-C and CBT-C affect hormone and stress levels in caregivers' saliva samples. In addition, this trial will enroll cancer patients in this study to see how their caregivers' participation in ERT-C or CBT may affect the patients' quality of life, stress, and use of healthcare services. Participants who become bereaved while on study will be given the option to withdraw or remain on study. Assessments for bereaved caregivers will not include the Caregiver Quality of Life Index-Cancer (CQOLC) or the Caregiver Reaction Assessment (CRA).


Description:

CBT-C and ERT-C are each 8-session, individual, caregivers-directed interventions delivered by a trained study therapist listed on the face page and facilitated by a manualized workbook with between-session practice exercises. To accommodate caregivers and reduce compliance issues with attendance of sessions, the 8 sessions are to be completed within 8 to 16 weeks from initiation of the first session. Each session is 60 minutes in length and will be audio and video recorded for MSK participants; sessions will only be audio recorded for MGH participants. Specific modules and intervention components are described below. To accommodate as many caregivers as possible and in response to the restrictions placed on caregivers currently in the context of the COVID-19 pandemic, sessions will be offered via telepsychiatry (using WebEx , Zoom, Teams). Training case participants will be identified and consented onto the study for training purposes only. Participants who are consented as training cases will not be randomized and will not complete any assessments. Data collected on training cases will be used for training and supervision purposes on this study only. These records will not be shown outside of the study supervisors, therapist in training, and staff.


Recruitment information / eligibility

Status Recruiting
Enrollment 480
Est. completion date January 8, 2025
Est. primary completion date January 8, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Caregivers: - As per self-report, age 18 years or older. - As per self-report, are a caregiver to an MSK or MGH patient with any site/stage of cancer who has received any type of treatment (e.g. curative, palliative) in the past 12 months. - Experience distress as evidenced by a score of 4 or greater on the Distress Thermometer (DT) and answer "Yes" to at least one of the follow-up questions (i.e. reporting that their distress is related to their caregiving experience, or their distress started or is related to caregiving or has gotten worse since the patient was diagnosed or began treatment. (N/A for training case participants) - English fluent: Self-report by subject identifying English as the preferred language for healthcare, and self-reported degree of fluency as speaking English "Very well." - As per self-report, residing in New York or New Jersey (for MSK participants), or Massachusetts (for MGH participants), or have the ability to complete sessions while complying with current telehealth regulations. Patients: - Age 18 years or older as per EMR. - Patient of an eligible caregiver per self-report or the EMR. - English speaking as per the EMR or self report by subject identifying English as the preferred language for healthcare, and self-reported degree of fluency as speaking English "Very well.". Exclusion Criteria: Caregivers: - As per self-report, presence of disorder that compromises comprehension of assessments or informed consent information (e.g., dementia). - As per the judgement of the consenting professional, clinical, PI, and/or as per the medical record, severe psychopathology or cognitive impairment which is likely to interfere with the participation or completion of the protocol or their ability to provide meaningful information - As per self-report, currently engaged in regular individual psychotherapeutic support (that the participant is unable or unwilling to put on hold for the course of treatment). - As per self-report, a lifetime history of bipolar disorder, schizophrenia, or schizoaffective disorder. - As per self-report, has medical condition or medication use known to confound measures of systemic inflammation (e.g., autoimmune disorder, inflammatory disease; uncontrolled thyroid disease; active infection; myocardial infarction or stroke in the last 6 months; Type I diabetes; acute hepatitis; recent vaccination for viral disease). (N/A for training case participants) - As per self-report, is a regular smoker, defined as having more than 2 cigarettes per day on most days. (N/A for training case participants) - As per self-report, providing care for a patient who has a caregiver is currently or formerly enrolled in this study ('formerly enrolled' is N/A for training case participants). - As per self-report, currently enrolled in another study focused on supportive care for caregivers (MGH participants only). Patients: - Presence of disorder that compromises comprehension of assessments or informed consent information (e.g., dementia) as per EMR or clinician judgment. - As per the judgement of the consenting professional, clinical, PI, and/or as per the medical record, severe psychopathology or cognitive impairment which is likely to interfere with the participation or completion of the protocol or their ability to provide meaningful information

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C)
The sessions are outlined as follow: psychoeducation, goal-setting, and describing the rationale for CBT (Session 1); coping effectiveness training (Session 2); identifying unhelpful cognitions and dysfunctional beliefs (Session 3); challenging and restructuring unhelpful cognitions (Session 4); behavioral activation within the limitations of the caregiving context (Session 5); problem-solving (Session 6); communication strategies and assertiveness training (Session 7); consolidating gains, maintenance, and relapse prevention (Session 8).
Emotion Regulation Therapy for Cancer Caregivers (ERT-C)
The sessions are outlined as follow: psychoeducation and motivation/dysregulation cue detection within caregiving contexts (Session 1); attention regulation skills training (Sessions 1-2); training in metacognitive skills (Sessions 3-4); exposure to proactive living in the face of risk and loss while applying skills (Sessions 5-7); consolidating gains, taking larger proactive steps, and relapse prevention (Session 8).

Locations

Country Name City State
United States Massachusetts General Hospital Boston Massachusetts
United States Memorial Sloan Kettering Cancer Center New York New York

Sponsors (5)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center Columbia University, University of Aarhus, University of California, University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes in anxiety symptoms as assessed via the HADS Developed by Zigmond and Snaith in 1983, the HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Items of the overall severity of anxiety and depression are rated on a five-point (0-4) severity scales (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0-21 for each subscale. A higher score indicates higher distress up to 6 months
Primary changes in depressive symptoms as assessed via the HADS Developed by Zigmond and Snaith in 1983, the HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Items of the overall severity of anxiety and depression are rated on a five-point (0-4) severity scales (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0-21 for each subscale. A higher score indicates higher distress up to 6 months
See also
  Status Clinical Trial Phase
Completed NCT03707548 - BPT to Improve Bodily Disturbances in Post-treatment Cancer Patients N/A
Not yet recruiting NCT06463782 - Clinical Study of 68Ga-LNC1007 Injection PET/CT Phase 1
Not yet recruiting NCT04493450 - NEMO - an App for Side Effect Management in Oncology
Completed NCT05604820 - The Effect of Progressive Muscle Relaxation Exercise on Sleep Quality N/A
Completed NCT04024748 - Verification of Imaging System PCD-1000A
Completed NCT03320161 - A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project
Recruiting NCT05547282 - Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure N/A
Recruiting NCT01742143 - Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Completed NCT05368116 - Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects . N/A
Recruiting NCT01603316 - Food: A Three-Arm Study Examining Food Insecurity Interventions Phase 2
Recruiting NCT03100071 - Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
Completed NCT04037410 - Environmental Temperature and White Adipose Tissue in Cancer Patients
Recruiting NCT06305741 - A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers N/A
Recruiting NCT05279378 - Correlation of Lung Ultrasonography With Chest CT Findings in Cancer Patients With COVID-19 Viral Pneumonia
Completed NCT03536702 - Effect of Group Led Creative Writing on Mood in Cancer Patients N/A
Not yet recruiting NCT05922423 - Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence N/A
Completed NCT01704469 - A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients N/A
Active, not recruiting NCT06348940 - Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients N/A
Completed NCT04302792 - New Food Solutions for Cancer Patients N/A
Recruiting NCT05219851 - The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors